Your browser doesn't support javascript.
loading
Tenascin-C increases lung metastasis by impacting blood vessel invasions.
Sun, Zhen; Velázquez-Quesada, Inés; Murdamoothoo, Devadarssen; Ahowesso, Constance; Yilmaz, Alev; Spenlé, Caroline; Averous, Gerlinde; Erne, William; Oberndorfer, Felicitas; Oszwald, Andre; Kain, Renate; Bourdon, Catherine; Mangin, Pierre; Deligne, Claire; Midwood, Kim; Abou-Faycal, Chérine; Lefebvre, Olivier; Klein, Annick; van der Heyden, Michael; Chenard, Marie-Pierre; Christofori, Gerhard; Mathelin, Carole; Loustau, Thomas; Hussenet, Thomas; Orend, Gertraud.
Afiliação
  • Sun Z; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • Velázquez-Quesada I; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • Murdamoothoo D; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • Ahowesso C; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • Yilmaz A; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • Spenlé C; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • Averous G; Department of Pathology, University Hospital Strasbourg, Strasbourg, France.
  • Erne W; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • Oberndorfer F; Department of Pathology, Medical University of Vienna (MUW), Vienna, Austria.
  • Oszwald A; Department of Pathology, Medical University of Vienna (MUW), Vienna, Austria.
  • Kain R; Department of Pathology, Medical University of Vienna (MUW), Vienna, Austria.
  • Bourdon C; Etablissement Français du Sang, INSERM U949, Strasbourg, France.
  • Mangin P; Etablissement Français du Sang, INSERM U949, Strasbourg, France.
  • Deligne C; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
  • Midwood K; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
  • Abou-Faycal C; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • Lefebvre O; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • Klein A; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • van der Heyden M; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • Chenard MP; Department of Pathology, University Hospital Strasbourg, Strasbourg, France.
  • Christofori G; Department Medicine, University Basel, Basel, Switzerland.
  • Mathelin C; Department of breast diseases and surgery, Strasbourg University Hospital, Strasbourg, France.
  • Loustau T; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • Hussenet T; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
  • Orend G; INSERM U1109 - MN3T, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy and, the Tumor Microenvironment group, France; Université de Strasbourg, Strasbourg, France; LabEx Medalis, Université de Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbou
Matrix Biol ; 83: 26-47, 2019 10.
Article em En | MEDLINE | ID: mdl-31288084
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasos Sanguíneos / Receptor ErbB-2 / Tenascina / Neoplasias Pulmonares / Neoplasias Mamárias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vasos Sanguíneos / Receptor ErbB-2 / Tenascina / Neoplasias Pulmonares / Neoplasias Mamárias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article